+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Estimation of radiation doses for Nagasaki atomic bomb survivors based on the ABS93D (Atomic Bomb Survivor 1993 Dose)



Estimation of radiation doses for Nagasaki atomic bomb survivors based on the ABS93D (Atomic Bomb Survivor 1993 Dose)



Nagasaki Igakkai Zasshi 72(1): 30-46



The dosimetry system of ABS93D (Atomic Bomb Survivor 1993 Dose) was constructed by the Research Institute for Radiation Biology and Medicine, Hiroshima University, based on DS86 (Dosimetry System 1986). We applied the ABS93D dosimetry system to atomic bomb survivors in Nagasaki, who were registered at Scientific Data Center for the A-Bomb Disaster, Nagasaki University School of Medicine, and estimated their radiation dose.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008626194

Download citation: RISBibTeXText


Related references

Estimation of radiation dose for the Nagasaki A-bomb survivors by ABS93D. Nagasaki Igakkai Zasshi 69(SPEC ISSUE): 393-396, 1994

A review of lung cancer in the atomic bomb survivors Treated cases at Nagasaki Atomic Bomb Hospital from 1983-1993. Nagasaki Igakkai Zasshi 69(SPEC ISSUE): 496-498, 1994

Exposure to Atomic Bomb Radiation and Age-Related Macular Degeneration in Later Life: The Hiroshima-Nagasaki Atomic Bomb Survivor Study. Investigative Ophthalmology and Visual Science 56(9): 5401-5406, 2015

Supplement: Cancer Incidence in Atomic Bomb Survivors. Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan || Cancer Incidence in Atomic Bomb Survivors. Part II: Solid Tumors, 1958-1987. Radiation Research 137(2): S17-S67, 1994

Supplement: Cancer Incidence in Atomic Bomb Survivors. Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan || Cancer Incidence in Atomic Bomb Survivors. Part III: Leukemia, Lymphoma and Multiple Myeloma, 1950-1987. Radiation Research 137(2): S68-S97, 1994

Supplement: Cancer Incidence in Atomic Bomb Survivors. Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan || Cancer Incidence in Atomic Bomb Survivors. Part I: Use of the Tumor Registries in Hiroshima and Nagasaki for Incidence Studies. Radiation Research 137(2): S1-S16, 1994

Hematological observation of atomic bomb survivors living in Tokyo about ten years after atomic bomb explosions in Hiroshima and Nagasaki. Keio Jour Med 6(3): 99-112, 1957

Leukemia and radiation doses in atomic bomb survivors of hiroshima and nagasaki. Acta Haematologica Japonica 36(3): 304, 1973

Supplement: Cancer Incidence in Atomic Bomb Survivors. Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan || Cancer Incidence in Atomic Bomb Survivors. Part IV: Comparison of Cancer Incidence and Mortality. Radiation Research 137(2): S98-S112, 1994

Relationship between the radiation dose and chromosome aberrations in atomic bomb survivors of Hiroshima and Nagasaki. Journal of Radiation Research 19(2): 126-140, 1978

Delayed radiation effects in atomic-bomb survivors. Major observations by the Atomic Bomb Casualty Commission are evaluated. Science 166(3905): 569-574, 1969

Salivary gland tumors in atomic bomb survivors in relation to atomic bomb radiation and carcinogenesis. Journal of Radiation Research 15(1): 68, 1974

Medical Radiation Exposure among Atomic Bomb Survivors: Understanding its Impact on Risk Estimates of Atomic Bomb Radiation. Radiation Research 191(6): 507-517, 2019

Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow. Journal of the National Cancer Institute 69(2): 323-328, 1982

Genomic instability in the epidermis induced by atomic bomb (A-bomb) radiation: a long-lasting health effect in A-bomb survivors. Cancer 115(16): 3782-3790, 2009